COPD & Cor Pulmonale: New Rat Model for Research
- A novel rat model developed by researchers in Philadelphia closely mirrors the pathological and physiological changes seen in human chronic obstructive pulmonary disease (COPD)-associated cor pulmonale.
- COPD, a chronic respiratory disease marked by persistent breathing issues and airflow limitations, is a leading cause of death worldwide.
- Tao Wang, MD, phd, lead investigator at Guangzhou Medical University in China, saeid that the prognosis for those with COPD complex by cor pulmonale is generally poor, and...
Researchers have created a novel rat model that accurately replicates the complexities of COPD-associated cor pulmonale, a critical step forward in understanding this deadly lung disease. This innovative model, detailed in The American Journal of Pathology, allows scientists to study the interplay between lung and heart pathology more effectively. COPD, a notable global health threat, often leads to cor pulmonale, reducing the chances of patient survival. This new rat model, induced through cigarette smoke exposure, mimics key features including pulmonary hypertension, emphysema, and inflammation. by providing better tools for research on secondary_keyword, this advancement could revolutionize treatment strategies.News Directory 3 is excited about this growth. Discover what’s next in COPD research and potential new treatments!
Rat Model Mimics COPD-Associated Cor Pulmonale
Updated June 17,2025
A novel rat model developed by researchers in Philadelphia closely mirrors the pathological and physiological changes seen in human chronic obstructive pulmonary disease (COPD)-associated cor pulmonale. The study, published in The American Journal of Pathology, highlights the model’s potential to improve understanding of lung and heart pathology interactions and, ultimately, patient outcomes.
COPD, a chronic respiratory disease marked by persistent breathing issues and airflow limitations, is a leading cause of death worldwide. The World Health Institution reports that COPD was responsible for about 3.23 million deaths in 2019. Cor pulmonale, a right ventricle dysfunction resulting from pulmonary disease, affects roughly 6% of COPD patients annually and significantly worsens their prognosis. This condition also places a substantial economic strain on society. The progress of effective treatments has been hindered by a lack of animal models that accurately replicate the complex interplay between COPD and cor pulmonale.
Tao Wang, MD, phd, lead investigator at Guangzhou Medical University in China, saeid that the prognosis for those with COPD complex by cor pulmonale is generally poor, and current treatments are inadequate. Wang added that to address the urgent need for a better animal model of COPD-associated cor pulmonale, they dedicated themselves to developing a novel rat model to better emulate the human disease, providing valuable tools for future research and therapeutic development.
The researchers induced COPD-associated cor pulmonale in rats through chronic cigarette smoke exposure combined with left pulmonary artery ligation. Subsequent physiological, histological, and molecular analyses confirmed that the model replicated pulmonary dysfunction, emphysema, and inflammatory infiltration characteristic of COPD. It also reproduced key features of cor pulmonale, including right ventricular hypertrophy, fibrosis, capillary rarefaction, and hemodynamic changes associated with pulmonary hypertension. The study also indicated that inflammation and oxidative stress pathways could be significant therapeutic targets.
Lingdan Chen, MD, co-lead investigator, also from Guangzhou Medical University, said that the development of this novel rat model represents a significant step forward in the ability to study COPD-associated cor pulmonale. Chen added that by elucidating the underlying mechanisms of the disease and developing more effective therapeutic strategies, it provides an essential tool for overcoming the therapeutic challenges posed by this condition.
What’s next
the new model is expected to accelerate the finding of molecular insights and the identification of innovative therapeutic targets for COPD and cor pulmonale.